Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 9.89x is 58% below its estimated 5-year average of 23.34x, near the low end of its estimated 5-year range (0.52x–855.88x).
As of 2026-10-06T15:50:13.764Z. 96.05% below its estimated 12-month average of 250.43x.
Calculation as of: 2026-10-06T15:50:13.764Z.
Quote observation: 2026-10-06T15:50:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 031dd4b10f0f14a16e9eaccfeacbabe2220a5c10b94ef049f803708fa703ac6d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
9.89x
EV/SALES RATIO AVG TTM
250.43x
EV/SALES RATIO AVG 3Y
190.32x
EV/SALES RATIO AVG 5Y
23.34x
EV/SALES RATIO AVG 10Y
209.39x
EV/SALES RATIO AVG 15Y
45.10x
EV/SALES RATIO AVG 20Y
63.86x
CURRENT VS TTM AVG
-96.05%
CURRENT VS 3Y AVG
-94.80%
CURRENT VS 5Y AVG
-57.62%
CURRENT VS 10Y AVG
-95.28%
CURRENT VS 15Y AVG
-78.07%
CURRENT VS 20Y AVG
-84.51%
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 455 covered companies
CURRENT VS SECTOR MEDIAN
+135.48%
vs the sector median at left
Abeona Therapeutics Inc.
Market Cap
$288.87M
EV/Sales Ratio
9.89x
TTM Avg
250.43x
3Y Avg
190.32x
5Y Avg
23.34x
Market Cap
$290.91M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.74M
EV/Sales Ratio
0.58x
TTM Avg
2.42x
3Y Avg
2.68x
5Y Avg
2.39x
Market Cap
$283.42M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$283.92M
EV/Sales Ratio
N/A
TTM Avg
5.51x
3Y Avg
58.44x
5Y Avg
51.98x
Market Cap
$280.60M
EV/Sales Ratio
1.02x
TTM Avg
0.84x
3Y Avg
0.87x
5Y Avg
1.56x
Market Cap
$297.62M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$279.16M
EV/Sales Ratio
49.67x
TTM Avg
36.37x
3Y Avg
26.31x
5Y Avg
30.77x
Market Cap
$276.08M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | $288.87M | 9.89x | 250.43x | 190.32x | 23.34x |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.91M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $290.74M | 0.58x | 2.42x | 2.68x | 2.39x |
| Indaptus Therapeutics, Inc. (INDP)vs › | $283.42M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.92M | N/A | 5.51x | 58.44x | 51.98x |
| Aurora Cannabis Inc. (ACB)vs › | $280.60M | 1.02x | 0.84x | 0.87x | 1.56x |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $279.16M | 49.67x | 36.37x | 26.31x | 30.77x |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $276.08M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $303.05M | N/A | 727.13x | 2593.81x | 3058.46x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 10.00x |
| 2026-10-02 | 9.82x |
| 2026-10-01 | 9.77x |
| 2026-09-30 | 10.31x |
| 2026-09-29 | 10.11x |
| 2026-09-28 | 10.40x |
| 2026-09-25 | 10.65x |
| 2026-09-24 | 10.71x |
| 2026-09-23 | 10.94x |
| 2026-09-22 | 11.59x |
| 2026-09-21 | 11.25x |
| 2026-09-18 | 11.03x |
| 2026-09-17 | 11.07x |
| 2026-09-16 | 10.58x |
| 2026-09-15 | 10.80x |
| 2026-09-14 | 10.71x |
| 2026-09-11 | 10.69x |
| 2026-09-10 | 10.83x |
| 2026-09-09 | 11.52x |
| 2026-09-08 | 11.65x |
| 2026-09-04 | 11.99x |
| 2026-09-03 | 11.83x |
| 2026-09-02 | 11.88x |
| 2026-09-01 | 11.94x |
| 2026-08-31 | 11.65x |
| 2026-08-28 | 11.81x |
| 2026-08-27 | 12.08x |
| 2026-08-26 | 12.01x |
| 2026-08-25 | 12.46x |
| 2026-08-24 | 12.12x |
| 2026-08-21 | 12.19x |
| 2026-08-20 | 11.90x |
| 2026-08-19 | 12.28x |
| 2026-08-18 | 12.35x |
| 2026-08-17 | 11.85x |
| 2026-08-14 | 11.97x |
| 2026-08-13 | 22.10x |
| 2026-08-12 | 26.42x |
| 2026-08-11 | 26.19x |
| 2026-08-10 | 26.38x |
| 2026-08-07 | 25.57x |
| 2026-08-06 | 24.24x |
| 2026-08-05 | 23.85x |
| 2026-08-04 | 23.93x |
| 2026-08-03 | 22.26x |
| 2026-07-31 | 22.37x |
| 2026-07-30 | 22.57x |
| 2026-07-29 | 21.63x |
| 2026-07-28 | 20.82x |
| 2026-07-27 | 21.24x |
| 2026-07-24 | 20.93x |
| 2026-07-23 | 22.22x |
| 2026-07-22 | 22.37x |
| 2026-07-21 | 22.80x |
| 2026-07-20 | 22.61x |
| 2026-07-17 | 24.63x |
| 2026-07-16 | 24.71x |
| 2026-07-15 | 25.76x |
| 2026-07-14 | 24.87x |
| 2026-07-13 | 24.67x |
| 2026-07-10 | 24.55x |
| 2026-07-09 | 25.10x |
| 2026-07-08 | 23.85x |
| 2026-07-07 | 22.88x |
| 2026-07-06 | 21.94x |
| 2026-07-02 | 22.30x |
| 2026-07-01 | 20.93x |
| 2026-06-30 | 21.44x |
| 2026-06-29 | 19.41x |
| 2026-06-26 | 19.22x |
| 2026-06-25 | 19.02x |
| 2026-06-24 | 19.26x |
| 2026-06-23 | 19.65x |
| 2026-06-22 | 19.76x |
| 2026-06-18 | 19.84x |
| 2026-06-17 | 19.37x |
| 2026-06-16 | 19.37x |
| 2026-06-15 | 19.45x |
| 2026-06-12 | 18.91x |
| 2026-06-11 | 18.91x |
| 2026-06-10 | 18.25x |
| 2026-06-09 | 18.60x |
| 2026-06-08 | 18.32x |
| 2026-06-05 | 18.63x |
| 2026-06-04 | 20.04x |
| 2026-06-03 | 19.45x |
| 2026-06-02 | 19.53x |
| 2026-06-01 | 19.30x |
| 2026-05-29 | 19.88x |
| 2026-05-28 | 19.88x |
| 2026-05-27 | 19.53x |
| 2026-05-26 | 18.75x |
| 2026-05-22 | 18.56x |
| 2026-05-21 | 18.87x |
| 2026-05-20 | 18.09x |
| 2026-05-19 | 17.31x |
| 2026-05-18 | 18.28x |
| 2026-05-15 | 18.75x |
| 2026-05-14 | 19.18x |
| 2026-05-13 | 55.70x |
| 2026-05-12 | 55.36x |
| 2026-05-11 | 57.40x |
| 2026-05-08 | 57.86x |
| 2026-05-07 | 56.38x |
| 2026-05-06 | 59.11x |
| 2026-05-05 | 57.06x |
| 2026-05-04 | 58.43x |
| 2026-05-01 | 52.52x |
| 2026-04-30 | 52.86x |
| 2026-04-29 | 51.49x |
| 2026-04-28 | 51.72x |
| 2026-04-27 | 51.49x |
| 2026-04-24 | 52.06x |
| 2026-04-23 | 53.54x |
| 2026-04-22 | 54.79x |
| 2026-04-21 | 51.95x |
| 2026-04-20 | 53.09x |
| 2026-04-17 | 53.31x |
| 2026-04-16 | 51.95x |
| 2026-04-15 | 52.18x |
| 2026-04-14 | 49.79x |
| 2026-04-13 | 48.31x |
| 2026-04-10 | 46.61x |
| 2026-04-09 | 48.99x |
| 2026-04-08 | 46.15x |
| 2026-04-07 | 45.47x |
| 2026-04-06 | 44.90x |
| 2026-04-02 | 45.59x |
| 2026-04-01 | 42.86x |
| 2026-03-31 | 41.72x |
| 2026-03-30 | 38.88x |
| 2026-03-27 | 39.56x |
| 2026-03-26 | 40.02x |
| 2026-03-25 | 41.04x |
| 2026-03-24 | 40.02x |
| 2026-03-23 | 41.04x |
| 2026-03-20 | 41.38x |
| 2026-03-19 | 42.40x |
| 2026-03-18 | 42.52x |
| 2026-03-17 | 497.70x |
| 2026-03-16 | 523.46x |
| 2026-03-13 | 497.70x |
| 2026-03-12 | 524.82x |
| 2026-03-11 | 531.60x |
| 2026-03-10 | 549.23x |
| 2026-03-09 | 551.94x |
| 2026-03-06 | 509.90x |
| 2026-03-05 | 512.62x |
| 2026-03-04 | 526.18x |
| 2026-03-03 | 522.11x |
| 2026-03-02 | 538.38x |
| 2026-02-27 | 546.52x |
| 2026-02-26 | 557.37x |
| 2026-02-25 | 570.93x |
| 2026-02-24 | 584.49x |
| 2026-02-23 | 554.65x |
| 2026-02-20 | 565.50x |
| 2026-02-19 | 569.57x |
| 2026-02-18 | 546.52x |
| 2026-02-17 | 535.67x |
| 2026-02-13 | 531.60x |
| 2026-02-12 | 528.89x |
| 2026-02-11 | 538.38x |
| 2026-02-10 | 546.52x |
| 2026-02-09 | 547.87x |
| 2026-02-06 | 547.87x |
| 2026-02-05 | 516.68x |
| 2026-02-04 | 541.09x |
| 2026-02-03 | 566.86x |
| 2026-02-02 | 553.30x |
| 2026-01-30 | 542.45x |
| 2026-01-29 | 541.09x |
| 2026-01-28 | 507.19x |
| 2026-01-27 | 545.16x |
| 2026-01-26 | 556.01x |
| 2026-01-23 | 551.94x |
| 2026-01-22 | 579.06x |
| 2026-01-21 | 572.28x |
| 2026-01-20 | 572.28x |
| 2026-01-16 | 564.15x |
| 2026-01-15 | 591.27x |
| 2026-01-14 | 556.01x |
| 2026-01-13 | 542.45x |
| 2026-01-12 | 543.80x |
| 2026-01-09 | 556.01x |
| 2026-01-08 | 542.45x |
| 2026-01-07 | 560.08x |
| 2026-01-06 | 551.94x |
| 2026-01-05 | 560.08x |
| 2026-01-02 | 572.28x |
| 2025-12-31 | 566.86x |
| 2025-12-30 | 554.65x |
| 2025-12-29 | 580.42x |
| 2025-12-26 | 591.27x |
| 2025-12-24 | 585.84x |
| 2025-12-23 | 570.93x |
| 2025-12-22 | 589.91x |
| 2025-12-19 | 545.16x |
| 2025-12-18 | 519.40x |
| 2025-12-17 | 509.90x |
| 2025-12-16 | 530.24x |
| 2025-12-15 | 541.09x |
| 2025-12-12 | 579.06x |
| 2025-12-11 | 600.76x |
| 2025-12-10 | 593.98x |
| 2025-12-09 | 562.79x |
| 2025-12-08 | 547.87x |
| 2025-12-05 | 512.62x |
| 2025-12-04 | 512.62x |
| 2025-12-03 | 493.63x |
| 2025-12-02 | 469.22x |
| 2025-12-01 | 500.41x |
| 2025-11-28 | 539.74x |
| 2025-11-26 | 550.58x |
| 2025-11-25 | 513.97x |
| 2025-11-24 | 474.65x |
| 2025-11-21 | 459.73x |
| 2025-11-20 | 424.47x |
| 2025-11-19 | 421.76x |
| 2025-11-18 | 459.73x |
| 2025-11-17 | 463.80x |
| 2025-11-14 | 455.66x |
| 2025-11-13 | 466.51x |
| 2025-11-12 | 474.36x |
| 2025-11-11 | 346.08x |
| 2025-11-10 | 356.08x |
| 2025-11-07 | 351.08x |
| 2025-11-06 | 349.41x |
| 2025-11-05 | 377.74x |
| 2025-11-04 | 411.06x |
| 2025-11-03 | 447.71x |
| 2025-10-31 | 452.71x |
| 2025-10-30 | 497.69x |
| 2025-10-29 | 482.69x |
| 2025-10-28 | 531.01x |
| 2025-10-27 | 574.33x |
| 2025-10-24 | 564.33x |
| 2025-10-23 | 554.33x |
| 2025-10-22 | 552.67x |
| 2025-10-21 | 562.66x |
| 2025-10-20 | 567.66x |
| 2025-10-17 | 547.67x |
| 2025-10-16 | 562.66x |
| 2025-10-15 | 572.66x |
| 2025-10-14 | 542.67x |
| 2025-10-13 | 552.67x |
| 2025-10-10 | 544.34x |
| 2025-10-09 | 594.32x |
| 2025-10-08 | 574.33x |
| 2025-10-07 | 526.01x |
| 2025-10-06 | 541.00x |
| 2025-10-03 | 552.67x |
| 2025-10-02 | 537.67x |
| 2025-10-01 | 531.01x |
| 2025-09-30 | 531.01x |
| 2025-09-29 | 539.34x |
| 2025-09-26 | 557.66x |
| 2025-09-25 | 544.34x |
| 2025-09-24 | 575.99x |
| 2025-09-23 | 569.33x |
Showing the most recent 260 of 4,066 data points. The chart above shows the full history.